Explore the vast range of titles available.

Background. The Shingles Prevention Study (SPS) demonstrated zoster vaccine efficacy through 4 years postvaccination. A Short-Term Persistence Substudy (STPS) demonstrated persistence of vaccine efficacy for at least 5 years. A Long-Term Persistence Substudy (LTPS) was undertaken to further assess vaccine efficacy in SPS vaccine recipients followed for up to 11 years postvaccination. Study outcomes were assessed for the entire LTPS period and for each year from 7 to 11 years postvaccination. Methods. Surveillance, case determination, and follow-up were comparable to those in SPS and STPS. Because SPS placebo recipients were offered zoster vaccine before the LTPS began, there were no unvaccinated controls. Instead, SPS and STPS placebo results were used to model reference placebo groups. Results. The LTPS enrolled 6867 SPS vaccine recipients. Compared to SPS, estimated vaccine efficacy in LTPS decreased from 61.1% to 37.3% for the herpes zoster (HZ) burden of illness (BOI), from 66.5% to 35.4% for incidence of postherpetic neuralgia, and from 51.3% to 21.1% for incidence of HZ, and declined for all 3 outcome measures from 7 through 11 years postvaccination. Vaccine efficacy for the HZ BOI was significantly greater than zero through year 10 postvaccination, whereas vaccine efficacy for incidence of HZ was significantly greater than zero only through year 8. Conclusions. Estimates of vaccine efficacy decreased over time in the LTPS population compared with modeled control estimates. Statistically significant vaccine efficacy for HZ BOI persisted into year 10 postvaccination, whereas statistically significant vaccine efficacy for incidence of HZ persisted only through year 8.

Background. Herpes zoster (HZ) and postherpetic neuralgia (PHN) cause significant morbidity in older adults. The incidence and severity of HZ and PHN increase with age in association with an age-related decline in varicella-zoster virus (VZV)-specific cell-mediated immunity (VZV-CMI). VZV vaccines can boost VZV-CMI. Therefore, we tested the hypothesis that VZV vaccination would protect older adults against HZ and PHN. Methods. We enrolled 38,546 adults ⩾60 years of age in a randomized, double-blind, placebo-controlled trial of an investigational HZ vaccine and actively followed subjects for the development of HZ. The primary end point was the burden of illness due to HZ (HZ BOI), a composite measure of the incidence, severity, and duration of pain and discomfort caused by HZ. The secondary end point was the incidence of PHN. Results. Subject retention was >95%. HZ vaccine reduced the HZ BOI by 61.1% (95% confidence interval [CI], 51.1%–69.1%; P < .001) and reduced the incidence of PHN by 66.5% (95% CI, 47.5%–79.2%; P < .001). The incidence of HZ was also reduced by 51.3% (95% CI, 44.2%–57.6%; P < .001). HZ vaccine was well tolerated; injection site reactions were generally mild. HZ vaccine neither caused nor induced HZ. Conclusion. The Shingles Prevention Study demonstrated that HZ vaccine significantly reduced the morbidity due to HZ and PHN in older adults.

BackgroundA double-blind, placebo-controlled trial that involved 38,546 subjects ⩾60 years old demonstrated efficacy of a high-potency live-attenuated Oka/Merck varicella-zoster virus (VZV) vaccine. The trial included an immunology substudy to determine the relationship of VZV-specific immune responses to vaccination and clinical outcome MethodsThe immunology substudy enrolled 1395 subjects at 2 sites where blood samples obtained prior to vaccination, at 6 weeks after vaccination, and at 1, 2, and 3 years thereafter were tested for VZV-specific cell-mediated immunity (VZV-CMI) by γ-interferon ELISPOT and responder cell frequency assays and for VZV antibody by glycoprotein ELISA ResultsVZV-CMI and VZV antibodies were significantly increased in vaccine recipients at 6 weeks after vaccination. The vaccine-induced increases in VZV-CMI persisted during the 3 years of follow-up, although their magnitude decreased over time. The magnitude of these VZV-specific immune responses was greater in subjects 60–69 years old than in subjects ⩾70 years old ConclusionsThe zoster vaccine induced a significant increase in VZV-CMI and VZV antibody. The magnitude and duration of the boost in VZV-CMI in vaccine recipients and the relationship of this boost to age paralleled the clinical effects of the vaccine observed during the efficacy trial. These findings support the hypothesis that boosting VZV-CMI protects older adults against herpes zoster and postherpetic neuralgia

The thermoelectric skutterudite Ba 0.3 Co 4 Sb 12 is a promising candidate for waste heat recovery applications. Recently, it was demonstrated that the addition of silver nanoparticles (Ag NP ) to Ba 0.3 Co 4 Sb 12 increases both the thermoelectric figure of merit and electrical conductivity. This study is the first to examine the effect of Ag NP addition on the material’s mechanical properties. This study also found that the Young’s modulus, E , shear modulus, G , and bulk modulus, B , decreased linearly with increasing volume fraction porosity, P . Resonant ultrasound spectroscopy was employed to measure the elastic moduli, and Vickers indentation was used to determine the hardness, H , and fracture toughness, K C . Trends in the mechanical properties as a function of grain size, porosity, and the Ag NP are discussed in terms of the pertinent literature. While K C was independent of Ag NP addition, porosity, and grain size, both E and H decreased linearly with increasing porosity. In addition, this study is the first to identify (i) the Ag 3 Sb phase formed and (ii) the enhanced densification that occurs when the Ag NP is sintered with Ba 0.3 Co 4 Sb 12 powders, where both effects are consistent with the eutectic and peritectic reactions observed in the binary phase diagram Ag–Sb. These eutectic/peritectic reactions may also be linked to the enhancement of electrical conductivity previously observed when Ag is added to Ba 0.3 Co 4 Sb 12 . Also, similar beneficial eutectic/peritectic reactions may be available for other systems where conductive particles are added to other antimonides or other thermoelectric systems.

In this research paper, we obtain the equivalent symmetries of non-homogeneous second order delay differential equations with variable coefficients. Group methods have been used to do this. The approach followed by us to obtain a Lie type invariance condition for the second order delay differential equation is by using Taylor's theorem for a function of more than one variable. This Lie type invariance condition established by us in this paper, will be used to obtain the determining equations of the second order delay differential equation. We study certain cases under which the delay differential equation admits infinitesimal generators. Further, by performing symmetry analysis of this delay differential equation, the complete group classification for it has been made. Keywords: Delay differential equation, determining equations, Lie group, Lie invariance condition, splitting equation, symmetries.

A glucose-negative strain pfk1 pfk2 of Saccharomyces cerevisiae mutated in both the genes coding for the soluble phosphofructokinase brings about nearly 30fold overexpression of the particulate phosphofructokinase (PFKII) when transformed with multiple copies of PFK2. The overexpression is independent of the dosage of PFK1-encoded β subunit. The elevated enzyme activity correlates directly with the increased particulate association of the polypeptide encoded by PFK2. Multiple copies of the PFK2 gene appear to be the only requirement for overproduction of the particulate phosphofructokinase.

The soluble phosphofructokinase of Saccharomyces cerevisiae is composed of two polypeptides α and β encoded by two unlinked genes PFK1 and PFK2 respectively. We report here cloning of the gene PFK1 by complementation of a glucose-negative double mutant pfk1 pfk2 using a genomic library of yeast in a multicopy vector. The anaerobic growth of the transformants on glucose is also rescued when the plasmid carries PFK1 but not when it carries PFK2. The gene PFK1 alone restores soluble-enzyme activity even if the resident pfk2 allele is mutant. This suggests that the β subunit is the catalytic determinant of the enzyme.

Community-based breeding programs (CBBPs) for small ruminants have been suggested as alternatives to centralised, government-controlled breeding schemes which have been implemented in many developing countries. An innovative methodological framework on how to design, implement and sustain CBBPs was tested in three sites in Ethiopia: Bonga, Horro and Menz. In these CBBPs, the main selection trait identified through participatory approaches was 6-month weight in all three sites. In Horro and Bonga, where resources such as feed and water permitted larger litter sizes, twinning rate was included. Ten-year (2009 to 2018) performance data from the breeding programs were analysed using Average Information Restricted Maximum Likelihood method (AI-REML). Additionally, the socioeconomic impact of CBBPs was assessed. Results indicated that 6-month weight increased over the years in all breeds. In Bonga, the average increase was 0.21 ± 0.018 kg/year, followed by 0.18 ± 0.007 and 0.11 ± 0.003 kg/year in Horro and Menz, respectively. This was quite substantial in an on-farm situation. The birth weight of lambs did not improve over the years in Bonga and Horro sheep but significant increases occurred in Menz. Considering that there was no direct selection on birth weight in the community flock, the increased weights observed in Menz could be due to correlated responses, but this was not the case in Bonga and Horro. The genetic trend for prolificacy over the years in both Bonga and Horro flocks was positive and significant (P < 0.01). This increase in litter size, combined with the increased 6-month body weight, increased income by 20% and farm-level meat consumption from slaughter of one sheep per year to three. The results show that CBBPs are technically feasible, result in measurable genetic gains in performance traits and impact the livelihoods of farmers.

The refeeding syndrome is a potentially lethal complication of refeeding in patients who are severely malnourished from whatever cause. Too rapid refeeding, particularly with carbohydrate may precipitate a number of metabolic and pathophysiological complications, which may adversely affect the cardiac, respiratory, haematological, hepatic and neuromuscular systems leading to clinical complications and even death. We aimed to review the development of the refeeding syndrome in a variety of situations and, from this and the literature, devise guidelines to prevent and treat the condition. We report seven cases illustrating different aspects of the refeeding syndrome and the measures used to treat it. The specific complications encountered, their physiological mechanisms, identification of patients at risk, and prevention and treatment are discussed. Each case developed one or more of the features of the refeeding syndrome including deficiencies and low plasma levels of potassium, phosphate, magnesium and thiamine combined with salt and water retention. These responded to specific interventions. In most cases, these abnormalities could have been anticipated and prevented. The main features of the refeeding syndrome are described with a protocol to anticipate, prevent and treat the condition in adults.

Aim: We investigated changes in dung beetle β-diversity components along a subtropical elevational gradient, to test whether turnover or nestedness-related processes drive the dissimilarity of assemblages at spatial and temporal scales. Location: An elevational gradient (200-1,600 m a.s.l.) of the Atlantic Forest in southern Brazil. Methods: We investigated the extent to which β-diversity varied along the elevational gradient (six elevations) at both spatial (among sites at different elevations) and temporal (different months at the same site) scales. We compared both the turnover and nestedness-related dissimilarity of species and genera using multiple-site or multiple-month measures and tested whether these measurements were different from random expectations. Results: A mid-elevation peak in species richness along the elevational gradient was observed, and the lowest richness occurred at the highest elevations. We found two different groups of species, lowland and highland species, with a mixing of groups at intermediate elevations. The turnover component of β-diversity was significantly higher for both spatial (i.e. elevational) and temporal changes in species composition. However, when the data for genera by site were considered, the elevational turnover value decreased in relative importance. Nestedness-related processes are more important for temporal dissimilarity patterns at higher elevation sites. Main conclusions: Spatial and temporal turnover of dung beetle species is the most important component of β-diversity along the elevational gradient. High-elevation assemblages are not subsets of assemblages that inhabit lower elevations, but this relationship ceases when β-diversity is measured at the generic level. Environmental changes across elevations may be the cause of the differential establishment of distinctive species, but these species typically belong to the same higher taxonomic rank. Conservation strategies should consider elevational gradients in case-specific scenarios as they may contain distinct species assemblages in lowlands vs. highlands.